Everolimus-based immunosuppression in liver transplant recipients: a single-centre experience-Reference-Cited by-同舟云学术

Everolimus-based immunosuppression in liver transplant recipients: a single-centre experience

Published:2013-12-28 Issue:1 Volume:8 Page:137-145
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Cholongitas Εvangelos,Goulis Ioannis,Theocharidou Eleni,Antoniadis Nikolaos,Fouzas Ioannis,Giakoustidis Dimitrios,Imvrios George,Giouleme Olga,Papanikolaou Vasilios,Akriviadis Evangelos,Vasiliadis Themistoklis

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s12072-013-9492-6.pdf

Reference32 articles.

1. Calne RY. Immunosuppression in liver transplantation. N Engl J Med. 1994;331(17):1154–1155

2. de Mare-Bredemeijer EL, Metselaar HJ. Optimization of the use of Calcineurin inhibitors in liver transplantation. Best Pract Res Clin Gastroenterol. 2012;26(1):85–95

3. Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature. 1999;397(6719):530–534

4. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003;349(10):931–940

5. Vivarelli M, Cucchetti A, Piscaglia F, La BG, Bolondi L, Cavallari A, et al. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. Liver Transpl. 2005;11(5):497–503

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individualized management of immunosuppressants in liver transplant recipients by using a novel immune score system;American Journal of Translational Research;2024

2. Seven-year survival after peritoneal metastasis of hepatocellular carcinoma occurring 12 years after living donor liver transplantation;Annals of Liver Transplantation;2023-05-18

3. Lebendspende Lebertransplantation für erwachsene Empfänger;Organtransplantation mit Lebendspende;2023

4. mTORi‐based immunosuppression reduces HCC recurrence at the expense of increased adverse side effects: A systematic review and meta‐analysis;Clinical Transplantation;2022-12

5. A Reduction of Calcineurin Inhibitors May Improve Survival in Patients with De Novo Colorectal Cancer after Liver Transplantation;Medicina;2022-11-29